Clinical Characteristics of and Treatment Pattern for EGFR-Amplified Colorectal Cancer
This study may suggest a favorable predictive impact of EGFR amplification in patients treated with anti-EGFR CTx. However, the benefit of front-line anti-EGFR antibody treatment in this group was not notable.
Authors
- Hyehyun Jeong (ORCID: https://orcid.org/0000-0001-7277-6463)
- Yong Sang Hong (ORCID: https://orcid.org/0000-0001-5672-0072)
- Ji Sung Lee (ORCID: https://orcid.org/0000-0001-8194-3462)
- Deokhoon Kim (ORCID: https://orcid.org/0000-0002-3597-1048)
- Sun Young Kim (ORCID: https://orcid.org/0000-0002-5886-3920)
- Jihun Kim (ORCID: https://orcid.org/0000-0002-8694-4365)
- Jeong Eun Kim (ORCID: https://orcid.org/0000-0001-9766-1531)
- Seong‐Eun Kim (ORCID: https://orcid.org/0000-0002-4518-4208)
- Tae‐Won Kim (ORCID: https://orcid.org/0000-0002-5239-3833)
Institutions
- Ulsan College (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-01-10
- DOI
- https://doi.org/10.4143/crt.2024.569
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00